9713 |
Ab00104-1.1-BT |
Anti-hapten 4-hydroxy-3-nitrophenyl acetyl (NP) [B1-8] |
1 mg |
支 |
19920.00 |
9714 |
Ab00104-1.1 |
Anti-hapten 4-hydroxy-3-nitrophenyl acetyl (NP) [B1-8] |
200 μg |
支 |
4680.00 |
9715 |
Ab00103-30.11-BT |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
500 μg |
支 |
37080.00 |
9716 |
Ab00103-30.11 |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
50 μg |
支 |
6360.00 |
9717 |
Ab00103-23.0-BT |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
1 mg |
支 |
19920.00 |
9718 |
Ab00103-23.0 |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
200 μg |
支 |
4680.00 |
9719 |
Ab00103-20.0-BT |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
500 μg |
支 |
37080.00 |
9720 |
Ab00103-20.0 |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
50 μg |
支 |
6360.00 |
9721 |
Ab00103-2.0-BT |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
1 mg |
支 |
19920.00 |
9722 |
Ab00103-2.0 |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
200 μg |
支 |
4680.00 |
9723 |
Ab00103-19.0-BT |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
500 μg |
支 |
37080.00 |
9724 |
Ab00103-19.0 |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
50 μg |
支 |
6360.00 |
9725 |
Ab00103-16.0-BT |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
500 μg |
支 |
37080.00 |
9726 |
Ab00103-16.0 |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
50 μg |
支 |
6360.00 |
9727 |
Ab00103-14.0-BT |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
500 μg |
支 |
37080.00 |
9728 |
Ab00103-14.0 |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
50 μg |
支 |
6360.00 |